Skip to main content
. 2011 Feb 10;5:177–186. doi: 10.2147/OPTH.S16832

Figure 3.

Figure 3

Proportion of patients with complete resolution of anterior chamber inflammation A), complete resolution of anterior chamber cells B), complete resolution of anterior chamber flare C), and no (Grade 0) pain D) at each study visit.

Notes: Visit 4 = day 3 (±1 day); visit 5 = day 8 (±1 day); visit 6 = day 15 (±1 day); visit 7 = day 18 (±1 day). *P < 0.0001; P = 0.0008.

Abbreviation: LE, loteprednol etabonate.